IE
NVS icon

Israel Englander’s Novartis NVS Stock Holding History

Israel Englander’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35M Buy
21,400
+5,600
+35% +$840K ﹤0.01% 3362
2026
Q1 		$2.41M Buy
15,800
+8,100
+105% +$1.24M ﹤0.01% 3689
2025
Q4 		$1.06M Buy
7,700
+1,000
+15% +$131K ﹤0.01% 4441
2025
Q3 		$859K Hold
6,700
– – ﹤0.01% 4731
2025
Q2 		$811K Sell
6,700
-28,300
-81% -$3.19M ﹤0.01% 4567
2025
Q1 		$3.9M Buy
35,000
+18,500
+112% +$1.97M ﹤0.01% 3109
2024
Q4 		$1.61M Sell
16,500
-11,900
-42% -$1.27M ﹤0.01% 3809
2024
Q3 		$3.27M Sell
28,400
-26,400
-48% -$3M ﹤0.01% 3224
2024
Q2 		$5.83M Buy
54,800
+8,100
+17% +$813K ﹤0.01% 2583
2024
Q1 		$4.52M Buy
46,700
+37,000
+381% +$3.79M ﹤0.01% 2963
2023
Q4 		$979K Sell
9,700
-78,300
-89% -$7.56M ﹤0.01% 4182
2023
Q3 		$8.96M Buy
88,000
+23,900
+37% +$2.43M ﹤0.01% 2146
2023
Q2 		$6.47M Buy
+64,100
New +$6.41M ﹤0.01% 2419
2019
Q2 		– Sell
-223,200
Closed -$19.2M – 4347
2019
Q1 		$19.2M Buy
+223,200
New +$17.9M 0.03% 822
2015
Q2 		– Sell
-3,236
Closed -$286K – 3673
2015
Q1 		$286K Buy
+3,236
New +$287K ﹤0.01% 3069
2014
Q4 		– Sell
-6,026
Closed -$508K – 4179
2014
Q3 		$508K Buy
6,026
+1,450
+32% +$117K ﹤0.01% 2739
2014
Q2 		$371K Buy
+4,576
New +$360K ﹤0.01% 2760

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Israel Englander's NVS Position: Q2 2026 in Review

Israel Englander opened a new position in Novartis (NVS) in Q2 2026: 758,029 shares worth $119M. The stake represents 0.04% of the portfolio and ranks #442 among its holdings. This is a return to the name: Israel Englander previously reported a position in NVS as recently as Q4 2025.

Israel Englander first reported a position in NVS in Q2 2013 and has held it in 46 quarters since. The position peaked at $120M in Q3 2018. 1,615 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Israel Englander held 758,029 shares of Novartis worth $119M as of Q2 2026.
  • Novartis was a new Israel Englander position in Q2 2026.
  • Novartis made up 0.04% of Israel Englander's portfolio in Q2 2026, its #442 holding.
  • Israel Englander first reported a position in Novartis in Q2 2013 and has held it in 46 quarters since.
  • Israel Englander's Novartis position peaked at $120M in Q3 2018.
  • 1,615 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.